Moderna | MRNA - Interest Income


Moderna reported $72M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.06M 277K Mar/2026
Agios Pharmaceuticals USD 10.8M 1.62M Mar/2026
Alnylam Pharmaceuticals USD 26.6M 32K Mar/2026
Arrowhead Research USD 16.93M 66K Jun/2026
Biogen USD 37.9M 700K Mar/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Celltrion KRW 779M 157.66M Mar/2026
Dianthus Therapeutics USD 6.26M 2.61M Mar/2026
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
Incyte USD 38.12M 4.43M Jun/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Kangmei Pharma CNY 2.44M 635.78K Mar/2026
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Moderna USD 72M 2M Mar/2026
Pharma Mar EUR 1.63M 3.17M Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Qiagen NV USD 10.56M 9.44M Mar/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sarepta Therapeutics USD 7M 1.74M Mar/2026
Sartorius EUR 14.8M 5.3M Jun/2026
Tilray USD 12.83M 20.19M May/2024
Ultragenyx Pharmaceutical USD 6M 512K Mar/2026
United Therapeutics USD 31.5M 10.3M Jun/2026
Vertex Pharmaceuticals USD 120.6M 5.8M Jun/2026
Zealand Pharma A/S 74M 28.41M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M Mar/2026